Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Current Liabilities -----

What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Current Liabilities ratio of NATH BIOGENES (INDIA) is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2013-

How is Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2013 - -

Compare Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹324.0 Cr -1.9% 21% 12.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,663.2 Cr 2.1% 1% -18.7% Stock Analytics
KAVERI SEED COMPANY ₹4,853.8 Cr 2% 18.4% -40.5% Stock Analytics
VENKYS (INDIA) ₹2,258.9 Cr 7% 28.3% -6.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,059.0 Cr -1.7% 28.1% -17% Stock Analytics
INDO US BIOTECH ₹214.6 Cr -0% 4.2% -36.7% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1.9%

21%

12.6%

SENSEX

3.2%

5%

5.5%


You may also like the below Video Courses